![Danse Ted](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Danse Ted
Consultant / Advisor chez Pound Capital Ltd.
Profil
Danse Ted is currently working as an Advisor at Pound Capital Ltd.
Previously, he worked as a CEO at ISTA Pharmaceuticals, Inc. and NeuroTECH SA. He completed his undergraduate degree from the University of the Pacific.
Postes actifs de Danse Ted
Sociétés | Poste | Début |
---|---|---|
Pound Capital Ltd.
![]() Pound Capital Ltd. Investment ManagersFinance Pound Capital Ltd (Pound Capital) is an independent private equity firm founded in 2002. The firm is headquartered in Stamford. | Consultant / Advisor | - |
Anciens postes connus de Danse Ted
Sociétés | Poste | Fin |
---|---|---|
ISTA Pharmaceuticals, Inc.
![]() ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Directeur Général | - |
NeuroTECH SA
![]() NeuroTECH SA Medical SpecialtiesHealth Technology Neurotech's founders have many years of experience in the development of innovative (cochlear) implants and implantable recording/stimulation electrodes. Neurotech SA was incorporated in 1996 to design, develop, manufacture and market active implantable medical devices for the treatment of debilitating disorders by neurostimulation. The Company, in the heart of Europe near Brussels, has since acquired significant expertise in applied biomedical technology. | Directeur Général | - |
Formation de Danse Ted
University of the Pacific | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Pound Capital Ltd.
![]() Pound Capital Ltd. Investment ManagersFinance Pound Capital Ltd (Pound Capital) is an independent private equity firm founded in 2002. The firm is headquartered in Stamford. | Finance |
NeuroTECH SA
![]() NeuroTECH SA Medical SpecialtiesHealth Technology Neurotech's founders have many years of experience in the development of innovative (cochlear) implants and implantable recording/stimulation electrodes. Neurotech SA was incorporated in 1996 to design, develop, manufacture and market active implantable medical devices for the treatment of debilitating disorders by neurostimulation. The Company, in the heart of Europe near Brussels, has since acquired significant expertise in applied biomedical technology. | Health Technology |
ISTA Pharmaceuticals, Inc.
![]() ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |